| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 05/01/2013 | CN103070850A Composition of oral solid medicine having good vivo behaviors |
| 05/01/2013 | CN103070848A Losartan potassium gastric floating capsule and preparation method thereof |
| 05/01/2013 | CN103070833A Freeze-dried powder injection of propionyl-L-carnitine hydrochloride and preparation method of freeze-dried powder injection |
| 05/01/2013 | CN103070825A Curcumin particle suspension used for intramuscular injection and hypodermic injection, preparation method and application |
| 05/01/2013 | CN103070478A Cigarette holder device facilitating smoking cessation |
| 05/01/2013 | CN102698253B Adenosine disodium triphosphate composition |
| 05/01/2013 | CN102600099B Method for preparing sinomenine hydrochloride sustained release tablets by non-organic solvents |
| 05/01/2013 | CN102488675B Applications of flavonoid compound used in preventing or curing of inflammatory diseases |
| 05/01/2013 | CN102440972B Gliclazide tablet (II) and preparation method thereof |
| 05/01/2013 | CN102423308B Two bromophenol compounds and application of pharmaceutically-acceptable salts of two bromophenol compounds in preparation of protection drug |
| 05/01/2013 | CN102389510B Dioscorea nipponica Makino saponin extraction method |
| 05/01/2013 | CN102389452B Pharmaceutical composition for increasing heart coronary flow |
| 05/01/2013 | CN102362914B Chinese medicinal gels for preventing and treating phlebitis |
| 05/01/2013 | CN102337263B siRNA (Small interfering ribonucleic acid) capable of inhibiting expression of enterovirus 71 type gene, composition and application |
| 05/01/2013 | CN102335177B Brand-new oral solid pharmaceutical composition and preparation method thereof |
| 05/01/2013 | CN102327591B Phlegm-eliminating pill |
| 05/01/2013 | CN102319363B Hemorrhoid-pain ointment and preparation method thereof |
| 05/01/2013 | CN102309456B Irbesartan sodium micro composite powder and tablets and preparation method thereof |
| 05/01/2013 | CN102302553B Extraction method of key components of Chinese magnoliavine fruit medicament |
| 05/01/2013 | CN102266386B Scutellaria baicalensis extract and preparation method and uses thereof |
| 05/01/2013 | CN102233055B Pharmaceutical composition used for treating cerebral stroke, and preparation method thereof |
| 05/01/2013 | CN102166346B Lrrc10 micromolecules and application thereof to preparation of medicaments for treating myocardial hypertrophy |
| 05/01/2013 | CN102151327B Traditional Chinese medicinal patch for treating coronary disease and preparation method thereof |
| 05/01/2013 | CN102144999B Application of senkyunolide H in preparing medicine for preventing and curing cerebral apoplexy |
| 05/01/2013 | CN102106587B Preparation method and application of extracts from natural plants |
| 05/01/2013 | CN102026643B The use and method of the compound of fasudil and the pharmaceutical composition thereof |
| 05/01/2013 | CN101953880B Method for preparing pueraria flavonid |
| 05/01/2013 | CN101898995B Carvedilol phosphate salts and/or solvates thereof, corresponding compositions, and/or methods of treatment |
| 05/01/2013 | CN101889027B Alginic acid with low molecular weight, its salts, uses, preparative methods, pharmaceutical compositions and foods |
| 05/01/2013 | CN101812099B Flavonoids compound and synthesis method and application thereof |
| 05/01/2013 | CN101809005B Fused bicyclic compound |
| 05/01/2013 | CN101664408B Stabilization of hypoxia inducible factor (HIF) alpha |
| 05/01/2013 | CN101583367B Materials and methods for treating and managing angiogenesis-mediated diseases |
| 05/01/2013 | CN101300005B N-2 adamantanyl-2-phenoxy-acetamide derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 05/01/2013 | CN101277705B Agent for amelioration of insulin resistance |
| 04/30/2013 | USRE44186 Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method |
| 04/30/2013 | US8431589 2,4-diaminopyrimidine derivatives |
| 04/30/2013 | US8431557 Treatment of menopause-associated symptoms |
| 04/30/2013 | US8431540 Modified lysine-mimetic compounds |
| 04/30/2013 | US8431380 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 04/30/2013 | US8431149 Intravascular stent having an iridium oxide, gold, platinum, titanium or inert carbon coating, and a number or reservoirs with an antibiotic, anticoagulant, antiproliferative, bactericide, angiogenesis inhibitor, growth factor, or radionuclide; greater control of drug placement and coating durability |
| 04/30/2013 | US8431124 Methods for treating a disease characterized by an excess of hyaluronan by administering a soluble hyaluronidase glycoprotein (sHASEGP) |
| 04/30/2013 | US8431121 Specifically targeted catalytic antagonists and uses thereof |
| 04/30/2013 | CA2514921C Combined use of olmesartan medoxomil and azelnidipine or amlodipine for the treatment of arteriosclerosis and hypertension |
| 04/30/2013 | CA2383154C Baff receptor (bcma), an immunoregulatory agent |
| 04/25/2013 | WO2013059702A1 Cerivastatin to treat pulmonary disorders |
| 04/25/2013 | WO2013059194A1 Meldrum 's acid, barbituric acid and pyrazolone derivatives substituted with hydroxylamine as hno donors |
| 04/25/2013 | WO2013058632A2 Composition containing ohioensins f as a polytrichastrum alpinum-derived novel compound for preventing or treating arteriosclerosis |
| 04/25/2013 | WO2013058630A2 Composition containing stereocalpin a as a novel compound for preventing or treating arteriosclerosis |
| 04/25/2013 | WO2013058605A1 Pharmaceutical composition comprising fluoxetine as an active ingredient, for preventing or treating blood-brain barrier disorders |
| 04/25/2013 | WO2013058303A1 Medicinal composition |
| 04/25/2013 | WO2013057944A1 Novel spiroindoline compound, and medicinal agent comprising same |
| 04/25/2013 | WO2013057650A1 Novel substituted imidazopyrimidines as gpbar1 receptor modulators |
| 04/25/2013 | WO2013057580A1 Method for treating capillary hemangiomas |
| 04/25/2013 | WO2013057545A1 Acid addition salts of bosentan |
| 04/25/2013 | WO2013057527A2 Compounds for treatment of ishcemic injury |
| 04/25/2013 | WO2013057357A1 Method for identifying drugs of use in the treatment of cardiovascular diseases |
| 04/25/2013 | WO2013057205A1 Diazabicyclo- and diazaspiro-alkane derivatives as phosphodiesterase-5 inhibitors |
| 04/25/2013 | WO2013032184A3 Composition comprising pyrazino-triazine derivatives |
| 04/25/2013 | WO2013030218A4 Selective and reversible inhibitors of ubiquitin specific protease 7 |
| 04/25/2013 | WO2013019091A3 A COMPOUND FOR INHIBITING 11β-HYDROXY STEROID DEHYDROGENASE 1, AND A PHARMACEUTICAL COMPOSITION COMPRISING THE SAME |
| 04/25/2013 | WO2012174488A3 Agents and methods for treating ischemic and other diseases |
| 04/25/2013 | WO2012122340A8 Soluble guanylate cyclase activators |
| 04/25/2013 | US20130102657 Anti-angiogenic compositions and methods of use |
| 04/25/2013 | US20130102616 Polymorphic forms of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride |
| 04/25/2013 | US20130102073 Methods for making and using reprogrammed human somatic cell nuclei and autologous and isogenic human stem cells |
| 04/25/2013 | US20130101627 Composition with extracts from olive leaf, yarrow and rosemary for treating human diseases and conditions |
| 04/25/2013 | US20130101595 Antibodies that bind il-18 and methods of inhibiting il-18 activity |
| 04/25/2013 | US20130101580 Compositions and methods for prolonging lifespan |
| 04/25/2013 | US20130101577 Extended Soluble PH20 Polypeptides and uses thereof |
| 04/25/2013 | US20130101565 Use of carbonic anhydrase ii for producing a drug |
| 04/25/2013 | US20130101557 Recombinant Adenovirus Having Anti-Angiogenesis Activity |
| 04/25/2013 | US20130098357 Cerivastatin to treat pulmonary disorders |
| 04/25/2013 | CA2853084A1 Epinephrine nanoparticles, methods of fabrication thereof, and methods for use thereof for treatment of conditions responsive to epinephrine |
| 04/25/2013 | CA2852914A1 Meldrum 's acid, barbituric acid and pyrazolone derivatives substituted with hydroxylamine as hno donors |
| 04/25/2013 | CA2852830A1 Acid addition salts of bosentan |
| 04/25/2013 | CA2852618A1 Pharmaceutical composition |
| 04/25/2013 | CA2852615A1 Novel substituted imidazopyrimidines as gpbar1 receptor modulators |
| 04/25/2013 | CA2850277A1 Method for treating capillary hemangiomas |
| 04/25/2013 | CA2850273A1 Method of reducing facial flushing associated with systemic use of phosphodiesterase type 5 inhibitors |
| 04/24/2013 | EP2584040A1 Compounds for treatment of ischemic injury |
| 04/24/2013 | EP2583967A1 Crystal of amide compound |
| 04/24/2013 | EP2583720A1 Oxazolopyrimidines as Edg-1 receptor agonists |
| 04/24/2013 | EP2582729A1 Anti-axl antibodies and methods of use |
| 04/24/2013 | EP2582697A1 Nanostructured aprepitant compositions, process for the preparation thereof and pharmaceutical compositions containing them |
| 04/24/2013 | EP2582685A1 Process for the preparation of dronedarone |
| 04/24/2013 | EP2582682A1 Methods of treating lung disease |
| 04/24/2013 | EP2582372A1 Ranolazine for use for the treatment of pulmonary hypertension |
| 04/24/2013 | EP2582235A2 Oral treatment of digital ischemic lesions |
| 04/24/2013 | CN1726915B Nasal cavity drug delivery system and combination of naloxone hydrochloride and preparation method |
| 04/24/2013 | CN1653050B Opioid and opioid-like compounds and uses thereof |
| 04/24/2013 | CN103069000A Eggshell membrane solubilization method using enzymes |
| 04/24/2013 | CN103068821A 4 - aminoquinazolin- 2 - yl - 1 - pyrrazole - 4 - carboxylic acid compounds as prolyl hydroxylase inhibitors |
| 04/24/2013 | CN103068816A Crystal of amide compound |
| 04/24/2013 | CN103068810A Process for the preparation of dronedarone |
| 04/24/2013 | CN103068801A Thioacetate compounds, compositions and methods of use |
| 04/24/2013 | CN103068395A Therapeutic agent for disease |
| 04/24/2013 | CN103060159A Chrysanthemum wine |
| 04/24/2013 | CN103059165A Polysaccharide acylate and preparation method thereof |
| 04/24/2013 | CN103059100A New peptides useful as dual caspase-2/-6 inhibitor and biological application thereof |